Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 183 results.
User Information
Export Records
  1. 1.   Linked dual-class HIV resistance mutations are associated with treatment failure
  2. Boltz,Valerie; Shao,Wei; Bale,Michael; Halvas, Elias; Luke,Brian; McIntyre, James A.; Schooley, Robert T.; Lockman, Shahin; Currier, Judith S.; Sawe, Fred; Hogg, Evelyn; Hughes, Michael D.; Kearney,Mary; Coffin, John M.; Mellors, John W.
  3. JCI INSIGHT. 2019, OCT 3; 4(19):
  1. 2.   Heterogeneous antiretroviral drug distribution and HIV/SHIV detection in the gut of three species
  2. Thompson, Corbin G; Rosen, Elias P; Prince, Heather M A; White, Nicole; Sykes, Craig; de la Cruz, Gabriela; Mathews, Michelle; Deleage,Claire; Estes,Jake; Charlins, Paige; Mulder, Leila R; Kovarova, Martina; Adamson, Lourdes; Arora, Shifali; Dellon, Evan S; Peery, Anne F; Shaheen, Nicholas J; Gay, Cynthia; Muddiman, David C; Akkina, Ramesh; Victor Garcia, J; Luciw, Paul; Kashuba, Angela D M
  3. Science translational medicine. 2019, Jul 03; 11(499): pii: eaap8758..
  1. 3.   Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins
  2. Ahi, Yadvinder; Zhang, Shu; Thappeta, Yashna; Denman, Audrey; Feizpour, Amin; Gummuluru, Suryaram; Reinhard, Bjoern; Muriaux, Delphine; Fivash, Matt; Rein, Alan
  3. MBIO. 2016, Nov 22; 7(6): e01985.
  1. 4.   Localization of ASV Integrase-DNA Contacts by Site-Directed Crosslinking and their Structural Analysis
  2. Peletskaya, E.; Andrake, M.; Gustchina, A.; Merkel, G.; Alexandratos, J.; Zhou, D. W.; Bojja, R. S.; Satoh, T.; Potapov, M.; Kogon, A.; Potapov, V.; Wlodawer, A.; Skalka, A. M.
  3. Plos One. 2011, Dec; 6(12):
  1. 5.   The effects of RNase H inhibitors and nevirapine on the susceptibility of HIV-1 to AZT and 3TC
  2. Davis, C. A.; Parniak, M. A.; Hughes, S. H.
  3. Virology. 2011, Oct; 419(2): 64-71.
  1. 6.   An evaluation of the RNase H inhibitory effects of Vietnamese medicinal plant extracts and natural compounds
  2. Tai, B. H.; Nhut, N. D.; Nhiem, N. X.; Quang, T. H.; Nguyen, T. T. N.; Bui, T. T. L.; Huong, T. T.; Wilson, J.; Beutler, J. A.; Ban, N. K.; Cuong, N. M.; Kim, Y. H.
  3. Pharmaceutical Biology. 2011, Oct; 49(10): 1046-1051.
  1. 7.   Mechanisms and Factors that Influence High Frequency Retroviral Recombination
  2. Delviks-Frankenberry, K.; Galli, A.; Nikolaitchik, O.; Mens, H.; Pathak, V. K.; Hu, W. S.
  3. Viruses-Basel. 2011, Sep; 3(9): 1650-1680.
  1. 8.   Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques
  2. Kulkarni, V.; Jalah, R.; Ganneru, B.; Bergamaschi, C.; Alicea, C.; von Gegerfelt, A.; Patel, V.; Zhang, G. M.; Chowdhury, B.; Broderick, K. E.; Sardesai, N. Y.; Valentin, A.; Rosati, M.; Felber, B. K.; Pavlakis, G. N.
  3. Vaccine. 2011, Sep; 29(39): 6742-6754.
  1. 9.   Majority of CD4(+) T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule
  2. Josefsson, L.; King, M. S.; Makitalo, B.; Brannstrom, J.; Shao, W.; Maldarelli, F.; Kearney, M. F.; Hu, W. S.; Chen, J. B.; Gaines, H.; Mellors, J. W.; Albert, J.; Coffin, J. M.; Palmer, S. E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, Jul; 108(27): 11199-11204.
  1. 10.   4 '-C-Methyl-2 '-Deoxyadenosine and 4 '-C-Ethyl-2 '-Deoxyadenosine Inhibit HIV-1 Replication
  2. Vu, B. C.; Boyer, P. L.; Siddiqui, M. A.; Marquez, V. E.; Hughes, S. H.
  3. Antimicrobial Agents and Chemotherapy. 2011, May; 55(5): 2379-2389.
  1. 11.   Anti-HIV microbicide development: targeting the virus is the key
  2. O'Keefe, B. R.
  3. Future Virology. 2011, May; 6(5): 553-556.
  1. 12.   Phenotypic characterization of drug resistance-associated mutations in HIV-1 RT connection and RNase H domains and their correlation with thymidine analogue mutations
  2. Lengruber, R. B.; Delviks-Frankenberry, K. A.; Nikolenko, G. N.; Baumann, J.; Santos, A. F.; Pathak, V. K.; Soares, M. A.
  3. Journal of Antimicrobial Chemotherapy. 2011, Apr; 66(4): 702-708.
  1. 13.   Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy
  2. Barsov, E. V.
  3. Immunotherapy. 2011, Mar; 3(3): 407-421.
  1. 14.   Foamy Retrovirus Integrase Contains a Pol Dimerization Domain Required for Protease Activation
  2. Lee, E. G.; Roy, J.; Jackson, D.; Clark, P.; Boyer, P. L.; Hughes, S. H.; Linial, M. L.
  3. Journal of Virology. 2011, Feb; 85(4): 1655-1661.
  1. 15.   An Antiretroviral/Zinc Combination Gel Provides 24 Hours of Complete Protection against Vaginal SHIV Infection in Macaques
  2. Kenney, J.; Aravantinou, M.; Singer, R.; Hsu, M.; Rodriguez, A.; Kizima, L.; Abraham, C. J.; Menon, R.; Seidor, S.; Chudolij, A.; Gettie, A.; Blanchard, J.; Lifson, J. D.; Piatak, M.; Fernandez-Romero, J. A.; Zydowsky, T. M.; Robbiani, M.
  3. Plos One. 2011, Jan; 6(1): 10.
  1. 16.   Nanoinformatics: an emerging area of information technology at the intersection of bioinformatics, computational chemistry and nanobiotechnology
  2. Gonzalez-Nilo, F. G.-N. F.; Perez-Acle, T.; Guinez-Molinos, S.; Geraldo, D. A.; Sandoval, C.; Yevenes, A.; Santos, L. S.; Laurie, V. F.; Mendoza, H.; Cachau, R. E.
  3. Biological Research. 2011 44(1): 43-51.
  1. 17.   Synthesis and biological evaluation of novel dihydro-aryl/alkylsulfanyl-cyclohexylmethyl-oxopyrimidines (S-DACOs) as high active anti-HIV agents
  2. He, Y. P.; Long, J.; Zhang, S. S.; Li, C.; Lai, C. C.; Zhang, C. S.; Li, D. X.; Zhang, D. H.; Wang, H.; Cai, Q. Q.; Zheng, Y. T.
  3. Bioorganic & Medicinal Chemistry Letters. 2011, Jan; 21(2): 694-697.
  1. 18.   Transmitted raltegravir resistance in an HIV-1 CRF_AG-infected patient
  2. Boyd, S. D.; Maldarelli, F.; Sereti, I.; Ouedraogo, G. L.; Rehm, C. A.; Boltz, V.; Shoemaker, D.; Pau, A. K.
  3. Antiviral Therapy. 2011 16(2): 257-261.
  1. 19.   HIV-1 Continues To Replicate and Evolve in Patients with Natural Control of HIV Infection
  2. Mens, H.; Kearney, M.; Wiegand, A.; Shao, W.; Schonning, K.; Gerstoft, J.; Obel, N.; Maldarelli, F.; Mellors, J. W.; Benfield, T.; Coffin, J. M.
  3. Journal of Virology. 2010, Dec; 84(24): 12971-12981.
  1. 20.   Evaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replication
  2. Oguariri, R. M.; Adelsberger, J. W.; Baseler, M. W.; Imamichi, T.
  3. Virus Research. 2010, Nov; 153(2): 269-276.
  1. 21.   Selective Modulation of DNA Polymerase Activity by Fixed-Conformation Nucleoside Analogues
  2. Eoff, R. L.; McGrath, C. E.; Maddukuri, L.; Salamanca-Pinzon, S. G.; Marquez, V. E.; Marnett, L. J.; Guengerich, F. P.; Egli, M.
  3. Angewandte Chemie-International Edition. 2010, Oct 4; 49(41): 7481-7485.
  1. 22.   Structural basis of HIV-1 resistance to AZT by excision
  2. Tu, X. Y.; Das, K.; Han, Q. W.; Bauman, J. D.; Clark, A. D.; Hou, X. R.; Frenkel, Y. V.; Gaffney, B. L.; Jones, R. A.; Boyer, P. L.; Hughes, S. H.; Sarafianos, S. G.; Arnold, E.
  3. Nature Structural & Molecular Biology. 2010, Oct; 17(10): 1202-+.
  1. 23.   Nature, Position, and Frequency of Mutations Made in a Single Cycle of HIV-1 Replication
  2. Abram, M. E.; Ferris, A. L.; Shao, W.; Alvord, W. G.; Hughes, S. H.
  3. Journal of Virology. 2010, Oct; 84(19): 9864-9878.
  1. 24.   Comparison of standard PCR/cloning to single genome sequencing for analysis of HIV-1 populations
  2. Jordan, M. R.; Kearney, M.; Palmer, S.; Shao, W.; Maldarelli, F.; Coakley, E. P.; Chappey, C.; Wanke, C.; Coffin, J. M.
  3. Journal of Virological Methods. 2010, Sep; 168(1-2): 114-120.
  1. 25.   Structure-Activity Analysis of Vinylogous Urea Inhibitors of Human Immunodeficiency Virus-Encoded Ribonuclease H
  2. Chung, S. M.; Wendeler, M.; Rausch, J. W.; Beilhartz, G.; Gotte, M.; O'Keefe, B. R.; Bermingham, A.; Beutler, J. A.; Liu, S. X.; Zhuang, X. W.; Le Grice, S. F. J.
  3. Antimicrobial Agents and Chemotherapy. 2010, Sep; 54(9): 3913-3921.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel